Skip to main content
MCAG
OTC Industrial Applications And Services

Going Concern Warning Persists Amid Ineffective Controls; SPAC Extends Business Combination Deadline

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$13.27
Mkt Cap
$38.125M
52W Low
$9.69
52W High
$13.27
Market data snapshot near publication time

summarizeSummary

Mountain Crest Acquisition Corp. V reiterates its going concern warning and ineffective internal controls, while extending its business combination deadline to November 16, 2026, and relying on sponsor financing for operations.


check_boxKey Events

  • Going Concern Warning Persists

    The company continues to express substantial doubt about its ability to continue as a going concern, with a mandatory liquidation date of November 16, 2026, if a business combination is not completed.

  • Ineffective Internal Controls

    Management concluded that disclosure controls and procedures were not effective, citing material weaknesses due to prior financial restatements and issues with timely report filings.

  • Business Combination Deadline Extended

    The deadline to complete an initial business combination with CUBEBIO Co., Ltd. was extended to November 16, 2026, requiring further deposits into the trust account.

  • Increased Related Party Debt

    Promissory notes from the sponsor increased to $1.55 million outstanding as of March 31, 2026, up from $1.3 million at December 31, 2025, highlighting the company's reliance on sponsor financing for working capital.


auto_awesomeAnalysis

Mountain Crest Acquisition Corp. V continues to face substantial doubt about its ability to continue as a going concern, with a mandatory liquidation date of November 16, 2026, if it fails to complete a business combination. Management also reported that disclosure controls and procedures were not effective, citing prior financial restatements and late filings. While the company reported a reduced net loss and reversed a significant excise tax liability, its operations remain dependent on related-party financing from its sponsor. The ongoing business combination with CUBEBIO Co., Ltd. is critical for the SPAC's survival, and the extension of its deadline to November 16, 2026, provides a temporary reprieve. The stock is currently trading above its redemption value, suggesting market anticipation of a successful merger despite the severe underlying risks.

At the time of this filing, MCAG was trading at $13.27 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $38.1M. The 52-week trading range was $9.69 to $13.27. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MCAG - Latest Insights

MCAG
May 15, 2026, 6:01 AM EDT
Filing Type: 10-Q
Importance Score:
9
MCAG
Mar 16, 2026, 6:05 AM EDT
Source: Wiseek News
Importance Score:
7
MCAG
Mar 13, 2026, 5:33 PM EDT
Filing Type: 10-K
Importance Score:
9